Annual CFI
$59.43 M
+$166.80 M+155.35%
31 December 2023
Summary:
Trevi Therapeutics annual cash flow from investing activities is currently $59.43 million, with the most recent change of +$166.80 million (+155.35%) on 31 December 2023. During the last 3 years, it has risen by +$59.46 million (+185812.50%). TRVI annual CFI is now at all-time high.TRVI Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$7.67 M
+$4.90 M+176.99%
30 September 2024
Summary:
Trevi Therapeutics quarterly cash flow from investing activities is currently $7.67 million, with the most recent change of +$4.90 million (+176.99%) on 30 September 2024. Over the past year, it has dropped by -$10.31 million (-57.36%). TRVI quarterly CFI is now -60.96% below its all-time high of $19.64 million, reached on 30 June 2023.TRVI Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$15.19 M
-$10.31 M-40.44%
30 September 2024
Summary:
Trevi Therapeutics TTM cash flow from investing activities is currently $15.19 million, with the most recent change of -$10.31 million (-40.44%) on 30 September 2024. Over the past year, it has increased by +$16.91 million (+981.54%). TRVI TTM CFI is now -74.44% below its all-time high of $59.43 million, reached on 31 December 2023.TRVI TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRVI Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +155.3% | -57.4% | +981.5% |
| 3 y3 years | +10000.0% | +100.0% | +10000.0% |
| 5 y5 years | +10000.0% | +100.0% | +10000.0% |
TRVI Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +155.3% | -61.0% | +114.1% | -74.4% | +114.2% |
| 5 y | 5 years | at high | +155.3% | -61.0% | +114.1% | -74.4% | +114.2% |
| alltime | all time | at high | +155.3% | -61.0% | +114.1% | -74.4% | +114.2% |
Trevi Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.67 M(+177.0%) | $15.19 M(-40.4%) |
| June 2024 | - | $2.77 M(-134.2%) | $25.50 M(-39.8%) |
| Mar 2024 | - | -$8.09 M(-163.0%) | $42.38 M(-28.7%) |
| Dec 2023 | $59.43 M(-155.3%) | $12.85 M(-28.6%) | $59.43 M(-3549.1%) |
| Sept 2023 | - | $17.98 M(-8.4%) | -$1.72 M(-93.0%) |
| June 2023 | - | $19.64 M(+119.1%) | -$24.55 M(-75.0%) |
| Mar 2023 | - | $8.96 M(-118.6%) | -$98.41 M(-8.3%) |
| Dec 2022 | -$107.37 M(<-9900.0%) | -$48.31 M(+896.0%) | -$107.37 M(+81.8%) |
| Sept 2022 | - | -$4.85 M(-91.1%) | -$59.07 M(+8.9%) |
| June 2022 | - | -$54.22 M(<-9900.0%) | -$54.22 M(<-9900.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2021 | $0.00 | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2021 | - | $0.00(0.0%) | -$5000.00(-75.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $0.00(-100.0%) | -$20.00 K(-37.5%) |
| Dec 2020 | -$32.00 K(+255.6%) | -$5000.00(-66.7%) | -$32.00 K(+18.5%) |
| Sept 2020 | - | -$15.00 K(+25.0%) | -$27.00 K(+125.0%) |
| June 2020 | - | -$12.00 K(<-9900.0%) | -$12.00 K(+33.3%) |
| Dec 2019 | -$9000.00(-94.3%) | $0.00(0.0%) | -$9000.00(-91.1%) |
| Sept 2019 | - | $0.00(0.0%) | -$101.00 K(+1.0%) |
| June 2019 | - | $0.00(-100.0%) | -$100.00 K(-9.1%) |
| Mar 2019 | - | -$9000.00(-90.2%) | -$110.00 K(-30.4%) |
| Dec 2018 | -$158.00 K(+1115.4%) | -$92.00 K(-9300.0%) | -$158.00 K(+139.4%) |
| Sept 2018 | - | $1000.00(-110.0%) | -$66.00 K(-1.5%) |
| June 2018 | - | -$10.00 K(-82.5%) | -$67.00 K(+17.5%) |
| Mar 2018 | - | -$57.00 K | -$57.00 K |
| Dec 2017 | -$13.00 K | - | - |
FAQ
- What is Trevi Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Trevi Therapeutics?
- What is Trevi Therapeutics annual CFI year-on-year change?
- What is Trevi Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Trevi Therapeutics?
- What is Trevi Therapeutics quarterly CFI year-on-year change?
- What is Trevi Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Trevi Therapeutics?
- What is Trevi Therapeutics TTM CFI year-on-year change?
What is Trevi Therapeutics annual cash flow from investing activities?
The current annual CFI of TRVI is $59.43 M
What is the all time high annual CFI for Trevi Therapeutics?
Trevi Therapeutics all-time high annual cash flow from investing activities is $59.43 M
What is Trevi Therapeutics annual CFI year-on-year change?
Over the past year, TRVI annual cash flow from investing activities has changed by +$166.80 M (+155.35%)
What is Trevi Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of TRVI is $7.67 M
What is the all time high quarterly CFI for Trevi Therapeutics?
Trevi Therapeutics all-time high quarterly cash flow from investing activities is $19.64 M
What is Trevi Therapeutics quarterly CFI year-on-year change?
Over the past year, TRVI quarterly cash flow from investing activities has changed by -$10.31 M (-57.36%)
What is Trevi Therapeutics TTM cash flow from investing activities?
The current TTM CFI of TRVI is $15.19 M
What is the all time high TTM CFI for Trevi Therapeutics?
Trevi Therapeutics all-time high TTM cash flow from investing activities is $59.43 M
What is Trevi Therapeutics TTM CFI year-on-year change?
Over the past year, TRVI TTM cash flow from investing activities has changed by +$16.91 M (+981.54%)